Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin versus another oral antidiabetic added to metformin in older adults with type 2 diabetes
2010-020460-38Phase 4Completed
- Sponsor
- Novartis
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of vildagliptin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Novartis. Primary endpoint: Percentage of patients without hypoglycemia over 6 months. Started Jul 2010; status: completed.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2010-020460-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020460-38.